Background/objectives Previous studies have linked maternal pre-pregnancy obesity (BMI ≥30 kg/m 2 ) with suboptimal neurodevelopment in her offspring; however, the literature is not entirely consistent. Whether these effects are muddled by maternal self-reports of pre-pregnancy weight and height, or are driven or amplified by the well often comorbid hypertensive and diabetic pregnancy and pre-pregnancy disorders, remains unclear. We examined whether maternal early pregnancy obesity is associated with developmental delay in her offspring, and if the associations are driven or amplified by diabetic and hypertensive pregnancy and pre-pregnancy disorders. Subjects/methods A total of 2504 mother-child dyads participated in the Prediction and Prevention of Pre-eclampsia and Intrauterine Growth Restriction (PREDO) study. Data on maternal early pregnancy obesity, pre-pregnancy, and gestational hypertension, pre-eclampsia, type 1 and gestational diabetes were derived from the Finnish Medical Birth Register. At the child's mean age of 42.1 (SD = 8.2) months the mothers completed the Ages and Stages Questionnaire (ASQ) Third edition for developmental milestones. Results Children of obese mothers had 1.81-2.74 (p-values <0.02) higher odds of failing to meet the development that is typical for a child's age (developmental domain score ≤−2SD below the child's age) on the communication, fine and gross motor, problem solving and personal/social skills and children of overweight mothers had 2.14 (p = 0.002) higher odds of failing to meet the development that is typical for the child's age on communication skills. Odds of developmental delay were also higher for children of mothers with pre-eclampsia and gestational diabetes. The associations were robust to covariates and confounders, the effects of overweight/obesity and pre-eclampsia were not driven by the other disorders, and overweight/obesity and hypertensive and diabetic disorders did not show additive effects. Conclusions Maternal early pregnancy overweight, obesity, and pre-eclampsia are independently associated with neurodevelopmental delay in her offspring. Further studies unraveling the underlying mechanisms are warranted.
Introduction
Maternal obesity during pregnancy has become one of the major challenges of obstetric care [1] . Of the world's adult population of women, including women of the childbearing age, 14% were obese in 2014 [1] . This number is forecasted to increase to 21% by 2025 [1] . The risks of obesity for pregnant mothers include gestational diabetes and hypertension spectrum pregnancy disorders, caesarian section delivery and for the offspring preterm birth, intrauterine growth restriction, macrosomia and related illnesses and complications, stillbirth and congenital anomalies [2] .
Apart from increasing the long-term health risks for the mother, evidence also suggests that maternal pre-pregnancy/ early pregnancy obesity is associated with long-term neurodevelopmental adversities in the offspring [2] . These include child's general developmental delay [3] , developmental delays in gross motor skills, especially in sitting without support and crawling on hands and knees [4] , delays in fine motor skills [5] , lower intelligence quotient [6] [7] [8] [9] [10] , poorer verbal skills [11] , increased risk for symptoms of ADHD [11] [12] [13] , and diagnoses of ASD [3, 11] . Yet, some studies have reported null associations between maternal obesity and cognitive and motor function [14] , and some even beneficial effects on cognitive and language development in the offspring [15] .
With one exception that measured maternal weight and height at the first antenatal clinical visit [13] , the previous studies are limited by relying on maternal self-reported, and not objectively verified pre-pregnancy weight and height, in some studies even months after delivery [6, 8, 10, 11] , or by using a measure that pools self-reported data with data from medical records [3-5, 7, 9, 12, 14, 15] ; of note, in the Upstate KIDS study [5] only 1.6% of maternal weight and height measurements were self-reported. Self-reports of weight and height are well-known to be biased [16, 17] . This may result in misclassification of women into groups according to BMI. Hence, it still remains to be verified if neurodevelopmental disadvantages in the offspring can be assigned to maternal pre-pregnancy/early pregnancy obesity, and if some of the discrepancies in the previous literature arise from inaccuracies in anthropometric measurements.
Furthermore, it remains unknown if neurodevelopmental disadvantages in the offspring are specific to maternal prepregnancy/early pregnancy obesity, or are driven or amplified by the well often comorbid pregnancy disorders. Existing data suggest that gestational diabetes [18, 19] and hypertension spectrum pregnancy disorders [20] [21] [22] [23] may carry adverse neurodevelopmental consequences on the offspring that are independent of maternal pregnancy BMI or obesity. But whether the same holds true for maternal obesity independent of these other disorders, still remains unknown.
To address these gaps in the literature, we tested the hypothesis that maternal early pregnancy obesity, derived from the Finnish Medical Birth Register (MBR) [24] , comprising measurements verified at the first antenatal clinical visit when pregnancy weight gain is still minimal, is associated with delays in developmental milestones in the 23-69-month-old offspring. Because some studies suggest that neurodevelopmental adversities not only characterize offspring from obese, but from overweight pregnancies as well [7, 11] , we also tested the hypothesis that maternal overweight is associated with delays in the offspring developmental milestones. We further tested if the associations between overweight/obesity and child neurodevelopment were independent of the common comorbid disorders, namely gestational and pre-pregnancy hypertension, preeclampsia, gestational diabetes, and type 1 diabetes. We expected that these disorders, that otherwise complicate pregnancy, may partially explain any potential adverse effects of maternal overweight/obesity on offspring developmental milestones as the previous discrepant findings may also arise from different prevalence of these disorders in the previous studies samples. Finally, we tested whether exposure to any combination of these disorders amplified adverse neurodevelopmental effects on the offspring.
Subjects and methods

Study design and participants
The participants came from the Prediction and Prevention of Pre-eclampsia and Intrauterine Growth Restriction (PREDO) Study [25] . The PREDO study enrolled 4785 pregnant women, of whom 4777 (8 miscarriages or stillbirths) gave birth to a singleton live-born child between 2006 and 2010. The women were recruited to the study when they visited antenatal clinics at one of the ten study hospitals in the Southern and Eastern Finland for their first ultrasound screening between 12 + 0 and 13 + 6 weeks + days of gestation. To enrich the number of women with preeclampsia and intrauterine growth restriction in the PREDO sample, 969 women were recruited based on having one or more risk factors of pre-eclampsia, including pre-pregnancy obesity [25] .
In 2011-2012, 4586 women and their children were invited for a follow-up (one child had died, 33 did not have data in the MBR, 55 women had declined participation in a follow-up, for 100 women addresses were not traceable). Of them, 2667(58.2%) participated at a child's mean age of 42.1 months (range 23.2-68.8 months) and 2504(54.6%) provided valid age-appropriate data on child developmental milestones (163, 6.1%, filled in the developmental milestones questionnaire too early or too late for age, we allowed 30% deviation from questionnaire-specific age translating into 3 weeks at the youngest age group and 2.7 months in the oldest age group).
In comparison to those who were invited and did not participate (n = 1919), mothers of the children who participated were older (31.8 vs 31.1 years), more often primiparous (41.2 vs 35.4%), and had a higher level of education (37.5 vs 46.4% secondary or less, 26.6 vs 25.0% lower tertiary, 35.9 vs 28.6% upper tertiary) (p-values <0.001); there were no differences in other obstetric/perinatal characteristics.
Ethics committee approval
Ethics Committees of the Helsinki and Uusimaa Hospital District and participating hospitals approved the study protocol. All participants and parents/guardians provided written informed consent.
Overweight, obesity and related pregnancy and prepregnancy disorders Data were extracted from the MBR. Each diagnosis was further verified by a clinical jury for the subsample recruited based on their increased risk of pre-eclampsia and intrauterine growth restriction.
Early pregnancy BMI was calculated from weight and height verified by a nurse at the first visit to the antenatal clinic (M = 8 + 4 weeks + days, SD = 1 + 3 weeks + days of gestation), and categorized to normal weight (24.99 kg/ m 2 or less), overweight (25) (26) (27) (28) (29) .99 kg/m 2 ), and obese (30 kg/ m 2 or more) groups according to the WHO criteria; 86 women (3.4%) had a BMI below 18.5 kg/m 2 indicating underweight; the underweight and normal weight groups were pooled for the analyses (from here on referred to as 'normal weight'). At the mean 8th gestational week, pregnancy weight gain is still minimal. Hence, this measurement is a close proxy of pre-pregnancy BMI.
Gestational diabetes was defined as fasting, 1 or 2 h plasma glucose during a 75 g oral glucose tolerance test ≥5.1, 10.0, or 8.5 mmol/L that emerged or was first identified during pregnancy; Gestational hypertension as blood pressure ≥140/90 mmHg on ≥2 occasions at least 4 h apart in a woman who was normotensive before 20th week of gestation; Pre-eclampsia as blood pressure ≥140/90 mmHg on ≥2 occasions at least 4 h apart in a women who was normotensive before 20th week of gestation with proteinuria ≥300 mg/24 h.
We also identified women with type 1 diabetes (none of the women in our sample had type 2 diabetes) and with pre-pregnancy/chronic hypertension defined as blood pressure ≥140/90 mmHg present pre-pregnancy or diagnosed before 20th week of gestation.
Developmental milestones
The Ages and Stages Questionnaires (ASQ) Third edition [26] (translated into Finnish, back-translated and approved by the publisher) is a tool with excellent test-retest reliability, intra-observer reliability, internal consistency and concurrent validity, high sensitivity and specificity to screen children requiring further developmental assessment, monitoring or special education [26] [27] [28] . It comprises 30 ageappropriate items (in our sample for children aged 22.2-26.2, n = 83, 24.5-29.5, n = 83, 27.5-32.5, n = 108, 30.5-35.5, n = 241, 33.0-41.5, n = 450, 37.0-47.0, n = 564, 42.0-53.0, n = 702, 55.0-59.0, n = 239, and 54.0-69.0 months, n = 34) measuring communication, gross motor, fine motor, problem solving, and personal/ social skills.
Each of the five domains comprise six questions with response 'yes' (scored 10) indicating the child can master the skill, 'sometimes' (scored 5) if the skill is emerging or occasional, and 'not yet' (scored 0) if the child is not able perform the skill. On each of these domains, the scores range from 0 to 60 with the highest value indicating that the child can master the skill. According to the ASQ manual and validation studies [26] [27] [28] [29] , children whose domain score is ≤−2 SDs below the mean of the child's age were considered to fail to meet the development that is typical for the child's age, and hence display developmental delay on that specific domain. Scores between −2SDs> and ≤−1SDs below the mean of the child's age on any of the ASQ domains were considered to indicate milder developmental delay [29] . This milder criteria has also been recommended for screening purposes for agencies that have sufficient resources [26] . Children with scores >−1SD of the mean of the child's age were considered to display no developmental delay and hence to be developing typically for child's age. We also summed up the number of times the child displayed no developmental delay for child's age (scored 0), mild developmental delay for child's age (scored 1) and failed to meet the development that is typical for child's age (scored 2) on any of the five ASQ domains (range 0-10). This sumscore reflected severity and pervasiveness of the child's developmental delay across the five developmental domains.
Covariates and confounders
The following factors were included as covariates in our analysis: maternal age at childbirth (years), parity (primiparous/multiparous), delivery mode (vaginal/caesarian), maternal smoking during pregnancy (did not smoke/quit during first trimester/smoked throughout pregnancy), child's gestational age at delivery (weeks), birth weight (grams), and sex (boy/girl) with data extracted from patient case reports and/or the MBR, and maternal alcohol use during pregnancy (yes/no/missing) and education level (basic/secondary vs tertiary) as self-reported in a questionnaire given to the mothers at 12 + 0-13 + 6 weeks + days of gestation; and child's age at follow-up (years) which was reported in conjunction with filling in the ASQ.
Statistical analyses
We used multinomial logistic regression to test whether children of overweight and obese women in comparison to children of normal weight women had higher odds for displaying mild developmental delay or failed to meet the development that is typical for the child's age on any of the ASQ domains. We used continuation-ratio ordinal logistic regression when the developmental delay severity/pervasiveness sum-score was the outcome. We repeated these analyses by replacing maternal overweight/obesity by Table 1 Characteristics of the study population according to maternal early pregnancy normal weight, overweight, and obesity Data not available, n (%) 0 0 0 maternal gestational hypertension, pre-eclampsia and prepregnancy/chronic hypertension using women without these disorders as the comparison group; and maternal gestational and type 1 diabetes using women without these disorders as the comparison group. Unstandardized regression coefficients represent odds ratios (OR), and 95% confidence intervals (95% CI). In addition to the unadjusted effects, we report these associations as adjusted for the covariates and confounders.
To test whether any potential effects on child's developmental milestones were specific to maternal overweight, obesity, or related hypertensive and diabetic pregnancy and pre-pregnancy disorders, we conducted two additional analyses. First, we made adjustments for the mutual effects of these conditions. We then tested the effects of these conditions by excluding women with the other conditions from the analyses, e.g., when we tested the effects of overweight/obesity we excluded women with hypertensive and diabetic pregnancy and pre-pregnancy disorders from the analyses; Because overweight/obesity and the disorders were highly comorbid in our sample (Supplemental Table 1 ) and because we used the ASQ −2SD and −1SD cutoffs to identify developmental delay, our sample size permitted us to conduct the latter 'restricted' analyses only when we used the child's developmental delay severity/ pervasiveness sum-score as the outcome.
Finally, we tested whether exposure to any combination of overweight/obesity, and comorbid disorders (sum-score categorized into no disorder, one, two, or more disorders) added to the neurodevelopmental adversity in the offspring. An effect was considered additive if the increment in the odds of displaying more severe and pervasive developmental delay was significantly higher for children of mothers with two or more than just one disorder.
All statistical analyses were performed using SAS 9.4 (SAS Institute, Inc., Cary, NC, USA).
Results
Characteristics of the sample according to maternal early pregnancy normal weight, overweight, and obesity are presented in Table 1 . Supplemental Table 1 shows the prevalence of hypertensive and diabetic pregnancy and prepregnancy disorders according to maternal early pregnancy weight categories. Prevalence ratio of any one hypertensive or diabetic pregnancy and pre-pregnancy disorder was 2.05 and 3.86 times higher in the overweight and obese groups as Data not available, n (%) 0 0 0 compared to the normal weight group, respectively, and of any two hypertensive and diabetic pregnancy and prepregnancy disorders 5.75 and 16.86 times higher in the overweight and obese groups as compared to the normal weight group, respectively. Overweight and obesity partook in over 93% cases of co-morbidities (Table 1) . Table 2 shows the numbers of children who displayed mild developmental delay (−2SD> to ≤SD) and failed to meet the development that is typical for the child's age (≤−2SD) according to maternal early pregnancy BMI and hypertensive and diabetic pregnancy and pre-pregnancy disorders groups. The number of children in the delay categories in women with type 1 diabetes was too small for any analyses, therefore we do not present findings on type 1 diabetes.
Associations between maternal early pregnancy overweight and obesity and child's developmental milestones Table 3 shows that in the unadjusted models children of overweight mothers had higher odds of displaying mild developmental delay on communication and fine motor skills and of failing to meet the development on the communication skills that is typical for the child's age. These associations remained significant when we adjusted for covariates and confounders, and for comorbid disorders (Table 3) .
Children of obese mothers had higher odds of displaying mild developmental delay on fine motor skills and of failing to meet the development on communication, fine motor, gross motor, problem solving and personal-social skills that is typical for the child's age (Table 3 ). All the associations remained significant after adjustments for covariates and confounders and for comorbid disorders, except for two: the association with the mild delay in fine motor skills was rendered non-significant when adjusted for covariates and confounders and the association with failure to meet the development on problem solving skills that is typical for the child's age was rendered non-significant when adjusted for comorbid disorders (Table 3) . Table 4 shows that after all covariates and confounders adjustments and in models adjusted for comorbid disorders, children of overweight and obese mothers had higher odds of displaying more severe and pervasive developmental delay across the five ASQ domains. These effects did not change either when we excluded women with comorbid disorders from the analyses (Table 4 'restricted model').
Associations between maternal hypertensive and diabetic pregnancy and pre-pregnancy disorders and child's developmental milestones Table 3 shows that children of mothers with pre-eclampsia had higher odds of mild developmental delay on Table 3 ). The latter association with the communication skills was rendered non-significant when adjusted for maternal overweight/obesity and diabetic pregnancy and pre-pregnancy disorders (Table 3 ).
In the unadjusted and all adjustment models, children of mothers with gestational diabetes had higher odds of mild developmental delay on personal social skills and of failing to meet the development on communication skills that would be typical for the child's age (Table 3) . Maternal gestational diabetes was also associated with higher odds of failing to meet the development on gross motor and problems solving skills that would be typical for child's age, but these associations were rendered non-significant when adjusted for maternal overweight/obesity and hypertensive pregnancy and pre-pregnancy disorders (Table 3) . Table 4 shows that children of mothers with preeclampsia and gestational diabetes had higher odds of displaying more severe and pervasive developmental delay across the five ASQ domains (Table 4 ). The association with pre-eclampsia remained significant across all adjustment models and in the 'restricted model' with women with overweight/obesity and diabetic disorders excluded, but the association with gestational diabetes was rendered nonsignificant in the 'restricted model' (Table 4 ).
Finally, we tested whether the effects of maternal early pregnancy overweight/obesity and hypertensive and diabetic pregnancy and pre-pregnancy disorders were additive. While children of mothers with one (OR = 1.32, 95% CI 1.1,1.60, p = 0.004) and two or more of these conditions (OR = 1.52, 95% CI 1.18,1.98 p = 0.001) had an increased odds for displaying more severe and pervasive developmental delay, the increment in the odds between one and two or more conditions was not statistically significant (pvalue = 0.19).
Discussion
In this prospective pregnancy cohort study, maternal early pregnancy obesity was associated with delay in developmental milestones in her offspring aged 23-69 months. Children of obese women had 1.81-2.74 higher odds of failing to meet the development in communication, fine and gross motor, problems solving and personal-social skills that is typical for the child's age. When tested across all of these five domains, the delay these children displayed was more severe and pervasive. Maternal early pregnancy overweight was also associated with delay in developmental milestones, but this delay was evident on a narrower spectrum of skills, namely on communication and fine motor skills, and the delay in communication skills was mild. Yet, maternal early pregnancy overweight also predicted a more severe and pervasive developmental delay of the child across the five ASQ domains. These associations changed only a little when we adjusted for covariates and confounders and comorbid disorders. Exclusion of women with the comorbid disorders in the restricted analyses allowed us to entirely eliminate potential confounding/ effect modification by the comorbid disorders, and for the first time to demonstrate the independent effects of overweight and obesity on the severity and pervasiveness of the child's developmental delay across the different developmental domains.
Our study also revealed that maternal pre-eclampsia was associated with developmental delays in communication and gross motor skills and gestational diabetes with delays Pre-eclampsia vs no hypertensive disorder: Pre-pregnancy/chronic hypertension vs no hypertensive disorder: Adjusted for the overweight/obesity/or the other pregnancy and pre-pregnancy disorders c Number of cases born to the mothers with type 1 diabetes is too small to calculate OR Restricted model refers to analyses of overweight mothers excluding mother's with gestational and hypertensive pregnancy and pre-pregnancy disorders); analyses of overweight and obesity exclude mothers with gestational and hypertensive pregnancy and pre-pregnancy disorders (335 women were overweight,155 women were obese and 1529 women were normal weight without other conditions); analyses of hypertensive disorders exclude mothers with overweight, obesity and diabetic pregnancy and pre-pregnancy disorders (48, 48, and 27 women had gestational hypertension, pre-eclampsia or pre-pregnancy/chronic hypertension and 1529 had no hypertensive disorders without other conditions, respectively), and analyses of gestational diabetes exclude mothers with overweight, obesity and hypertensive pregnancy and pre-pregnancy disorders (74 women had gestational diabetes and 1529 women had no diabetic disorder without other conditions) in communication, gross motor, problem solving, and personal social skills. Both pre-eclampsia and gestational diabetes were associated with the score indicating more severe and pervasive developmental delay across the five ASQ domains. While these associations were not explained by the covariates and confounders, the restricted analyses revealed that only the associations between pre-eclampsia and the severity/pervasiveness score of developmental delay remained significant when women with overweight/obesity and diabetic pregnancy and pre-pregnancy disorders were excluded from the analyses. These findings combined with the finding that there were no additive effects of maternal early pregnancy overweight/ obesity and comorbid disorders on child neurodevelopmental adversity suggest that maternal overweight, obesity and pre-eclampsia may carry harmful effects on developmental delay of the child that are not, contrary to what we expected, explained by the comorbid disorders. Gestational diabetes carries similar harmful effects, but these are at least partially explained by maternal overweight/obesity and the other disorders. As the prevalence rates of maternal overweight and obesity and comorbid disorders are increasing, our findings carry an important public health message: prevention and effective management of maternal overweight/obesity and comorbid conditions should not only improve the quality of life and wellbeing of the pregnant mothers themselves, but decrease the burden of neurodevelopmental adversities in the next generation.
A major strength of the study relates to the study design: a fifth of our sample was recruited based on their known risk factor status for pre-eclampsia and IUGR. This resulted in an enrichment of the pregnancy and pre-pregnancy disorders in our sample, amplifying the statistical power to study their independent effects. Of note, when this study was performed, guidelines for gestational diabetes screening in Finland were changed from risk-based to comprehensive screening. Thus, our study is likely to include milder cases of gestational diabetes than previous studies [30] . Inclusion of milder cases of GDM may have resulted in finding associations with milder developmental delays in some skills, which is in line with our findings on overweight, suggesting dose-response associations. However, in interpretation the small number of children failing to meet the age-appropriate skills should be taken into account. The other strengths include a prospective study design, data of exposures derived from the MBR and medical records, and unlike in a majority of the previous studies measurements of weight and height conducted in the first antenatal clinic visit in early pregnancy, and a large and homogenous study sample. Even though the developmental milestones data were mother-reported, which may introduce a bias, and ASQ is a screening tool rather than a diagnostic instrument, the ASQ has been shown to be reliable, it is well-validated, and demonstrates high sensitivity and specificity to screen children requiring further developmental assessment, monitoring or special education [26] [27] [28] .
However, the underlying mechanisms still remain unknown. Experimental work in rodents suggests that the mechanisms that link maternal obesity with cognitive dysfunction in the offspring may include alterations in insulin, glucose and leptin regulation, inflammation, and decreased expression of brain-derived neurothropic factor, particularly in the hippocampus and cortex [31, 32] . A recent study showed that hyperglycemia in the pregnant rat can retard dendritic development in the fetal brain and that these changes are a result from abnormal insulin/IGF-I signaling in the fetal brain [33] . It is also possible that insulin resistance, characterizing human neonates from obese pregnancies [34, 35] , impedes neuronal growth in the fetal brain. Obesity is also associated with changes in the maternal microbiota [36] ; and these microbial changes are transferred from mothers to infants during delivery and breastfeeding [37] , with caesarian section/vaginal delivery, and breastfeeding/not breastfeeding influencing infant's microbiota differently [38] . Of note is that obese mothers have disproportionally high rates of caesarian section deliveries [39] . There is also evidence that maternal obesity is associated with delayed lactogenesis and reduced rates of breastfeeding [40] . Other mechanisms may relate to lifestyle behaviors, including unhealthier diet, and concomitant alterations in micro-and macronutrients, smoking, alcohol use and physical inactivity during pregnancy, and maternal socio-economic position. In our study the associations were independent of maternal smoking and alcohol use during pregnancy and maternal education, however. Clearly further studies unraveling the underlying mechanisms are warranted.
Another major study limitation is the follow-up sample attrition, which was not independent of maternal characteristics. The mothers of children who participated in this study were older, more often primiparous, and had on average higher educational attainment as compared to those who were eligible, but did not participate. This would be expected to cause bias only if the associations between maternal metabolic conditions and child development differ between participants and non-participants. Further, even though our study design resulted in a large number of overweight/obese women and women with hypertensive and diabetic pregnancy and pre-pregnancy disorders, the number of women with type 1 diabetes was small and precluded studying its effect entirely. In addition, although we were able to control for a number of potential covariates, we cannot entirely exclude the possibility of residual confounding. However, since the associations were consistently significant in largely all of the studied analytic models, we do not anticipate residual confounding to be a source of false-positive associations.
Conclusion
In all, our study findings show that maternal early pregnancy overweight, obesity, and pre-eclampsia are associated, independently of each other and the other comorbid disorders, with neurodevelopmental harm for the developing offspring. Gestational diabetes also carried neurodevelopmental harm, which was partially explained by maternal overweight/obesity and hypertensive disorders. Our findings suggest that efforts to optimize weight management and to reduce the incidence of modifiable pregnancy and pre-pregnancy disorders are likely to result in neurodevelopmental benefits in the offspring.
